Stock Research: Evolus

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Evolus

NasdaqGM:EOLS US30052C1071
23
  • Value
    11
  • Growth
    40
  • Safety
    Safety
    71
  • Combined
    25
  • Sentiment
    46
  • 360° View
    360° View
    23
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Evolus, Inc. is a performance beauty company focused on cash-pay aesthetic medical products. It operates in the medical aesthetics industry with product categories including injectable neurotoxins (Jeuveau) and injectable hyaluronic acid gels (Evolysse). Jeuveau is available in the United States, Canada, and certain European markets, while Evolysse is available in the United States and Europe. In the last fiscal year, the company had a market cap of $599 millions, profits of $182 millions, revenue of $266 millions, and 332 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 23 (better than 23% compared with alternatives), overall professional sentiment and financial characteristics for the stock Evolus are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Evolus. Only the consolidated Value Rank has an attractive rank of 71, which means that the share price of Evolus is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 71% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 40, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 11, meaning the company has a riskier financing structure than 89% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 54% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 46. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
71 4 65 43
Growth
40 81 87 97
Safety
Safety
11 9 13 6
Sentiment
46 90 54 76
360° View
360° View
23 33 59 64
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
93 95 54 31
Opinions Change
32 75 31 75
Pro Holdings
n/a 18 24 82
Market Pulse
35 89 89 40
Sentiment
46 90 54 76
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
71 4 65 43
Growth
40 81 87 97
Safety Safety
11 9 13 6
Combined
25 4 61 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
28 4 100 16
Price vs. Earnings (P/E)
72 41 40 62
Price vs. Book (P/B)
100 1 100 28
Dividend Yield
1 1 1 1
Value
71 4 65 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
81 87 89 79
Profit Growth
10 76 63 62
Capital Growth
68 45 43 83
Stock Returns
4 61 85 73
Growth
40 81 87 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
7 3 11 3
Refinancing
50 32 29 49
Liquidity
30 27 27 20
Safety Safety
11 9 13 6

Similar Stocks

Discover high‑ranked alternatives to Evolus and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

PriceSmart

NasdaqGS:PSMT
Country: USA
Industry: Hypermarkets, Super Centers
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.